Henry Schein Lowers 2026 Adjusted EPS Guidance Following Change to Non-GAAP Reporting
Henry Schein Updates Presentation of Non-GAAP Financial Measures
Henry Schein To Exclude Gains Resulting From Remeasurement To Fair Value Of Previously Held Equity Interests From Its Non-GAAP Financial Results; Updates FY26 Adjusted EPS Guidance To $5.42-$5.48 To Reflect The Change
CareQuest and Henry Schein Launch the BRIDGE Health Network to Advance Dental-Medical Integration
Is Henry Schein (HSIC) a Solid Growth Stock? 3 Reasons to Think "Yes"
Henry Schein (HSIC) Upgraded to Buy: What Does It Mean for the Stock?
HSIC vs. MMSI: Which Stock Should Value Investors Buy Now?
Is Henry Schein (HSIC) Stock Undervalued Right Now?
Henry Schein to Participate in Upcoming Investor Conferences in November and December
Henry Schein, Inc. 2026 Q3 - Results - Earnings Call Presentation
UBS Maintains Neutral on Henry Schein, Raises Price Target to $95
Henry Schein Stock What Changed After Its Earnings Beat
Evercore ISI Group Maintains Outperform on Henry Schein, Lowers Price Target to $100
Henry Schein Inc (HSIC) (Q3 2026) Earnings Call Highlights: Raised Guidance, Dental Share ...
Henry Schein (HSIC) Q3 2026 Earnings Call Transcript
What Henry Schein (HSIC) Said on Its Q3 Earnings Call
Henry Schein, Inc. Q3 2026 Earnings Call Summary
Henry Schein, Inc. (HSIC) Q3 2026 Earnings Call Transcript
Henry Schein Raises 2026 Earnings Outlook as Q3 Profit Beats Forecasts and Dental Sales Grow
Compared to Estimates, Henry Schein (HSIC) Q3 Earnings: A Look at Key Metrics
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.